KK
PRAX icon

KLP Kapitalforvaltning’s Praxis Precision Medicines PRAX Stock Holding History

KLP Kapitalforvaltning’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.74M Hold
5,200
– – 0.01% 849
2026
Q1 		$1.68M Buy
5,200
+800
+18% +$247K 0.01% 782
2025
Q4 		$1.3M Buy
4,400
+400
+10% +$74.5K 0.01% 891
2025
Q3 		$212K Buy
4,000
+1,200
+43% +$58.2K ﹤0.01% 1807
2025
Q2 		$118K Hold
2,800
– – ﹤0.01% 1989
2025
Q1 		$106K Hold
2,800
– – ﹤0.01% 2005
2024
Q4 		$215K Buy
+2,800
New +$203K ﹤0.01% 1790

Other funds holding PRAX

JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

KLP Kapitalforvaltning's PRAX Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Praxis Precision Medicines (PRAX) position steady in Q2 2026 at 5,200 shares worth $1.74M. The position accounts for 0.01% of the portfolio, ranked #849.

KLP Kapitalforvaltning first reported a position in PRAX in Q4 2024 and has held it in 7 quarters since. 310 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • KLP Kapitalforvaltning held 5,200 shares of Praxis Precision Medicines worth $1.74M as of Q2 2026.
  • KLP Kapitalforvaltning left its Praxis Precision Medicines share count unchanged in Q2 2026.
  • Praxis Precision Medicines made up 0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #849 holding.
  • KLP Kapitalforvaltning first reported a position in Praxis Precision Medicines in Q4 2024 and has held it in 7 quarters since.
  • 310 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.